HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Howard Grodman Selected Research

Sickle Cell Trait

1/2019Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Howard Grodman Research Topics

Disease

2Medulloblastoma
07/2009 - 06/2008
1Renal Cell Carcinoma (Grawitz Tumor)
01/2019
1Hemoglobinopathies
01/2019
1Sickle Cell Trait
01/2019
1Germinoma
07/2009
1Neoplasms (Cancer)
07/2009

Drug/Important Bio-Agent (IBA)

2Etoposide (VP 16)FDA LinkGeneric
07/2009 - 06/2008
1Carboplatin (JM8)FDA LinkGeneric
07/2009
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
07/2009
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2008
1Cisplatin (Platino)FDA LinkGeneric
06/2008
1Vincristine (Oncovin)FDA LinkGeneric
06/2008

Therapy/Procedure

2Drug Therapy (Chemotherapy)
07/2009 - 06/2008
1Therapeutics
01/2019
1Induction Chemotherapy
06/2008
1Craniospinal Irradiation
06/2008